Hi PH6,
A few from me:
(1) What's happening with MMJ's letter of intent with both Epilepsy Action Australia and Fresh Therapeutics?
(2) Are UG solely concentrating on cultivating OG Kush in the near-term for the other LP, or are they concurrently growing medicinal strains for the current Canadian MM market?
(3) A clinical trial is currently underway involving the 100mg CBD capsule, when can we expect to see the 100mg CBD capsule on the market?
(4) Is it within the confines of promotional legal constraints to provide information and links on the MMJ website to avail prospective patients with the know-how to access products offered by Satipharm?
Thanks!
Shareholder Questions to MMJ Management, page-25
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HGV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.833M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 291807 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 13115 | 1 |
View Market Depth
| Last trade - 16.12pm 26/07/2024 (20 minute delay) ? |
| HGV (ASX) Chart |
Day chart unavailable